Showing results (931-940 of 1,008) with videos related to
Sort By:
Pageof 101
The Journal of Molecular Diagnostics : JMD|May 7, 2026
Validation of MyHPVscore: a high-performance HPV ctDNA lab developed testJordan Currie, Heather Walline, Colleen G Hochfelder, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2019
Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck CancerCarryn M Anderson, Christopher M Lee, Deborah P Saunders, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 18, 2020
CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapyBenjamin S Rosen, Joel R Wilkie, Yilun Sun, et al.Proceedings of the National Academy of Sciences of the United States of America|May 11, 2021
Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communitiesQing Yang, Tassa K Saldi, Patrick K Gonzales, et al.Nature|May 1, 2009
Precise genome modification in the crop species Zea mays using zinc-finger nucleasesVipula K Shukla, Yannick Doyon, Jeffrey C Miller, et al.Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriersQing Yang, Nicholas R Meyerson, Stephen K Clark, et al.Proceedings of the National Academy of Sciences of the United States of America|September 25, 2019
A distinct lineage of giant viruses brings a rhodopsin photosystem to unicellular marine predatorsDavid M Needham, Susumu Yoshizawa, Toshiaki Hosaka, et al.Elife|March 29, 2021
Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriersQing Yang, Nicholas R Meyerson, Stephen K Clark, et al.JCO Precision Oncology|October 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyFrancis P Worden, Evan Pisick, Michael Rothe, et al.Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communitiesQing Yang, Tassa K Saldi, Erika Lasda, et al.Pageof 101